【市場調査レポート】パクスロビドAPIのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Paxlovid API Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。パクスロビドAPIのグローバル市場インサイト・予測（～2028年） / Global Paxlovid API Market Insights, Forecast to 2028 / QY2207E01894資料のイメージです。

• レポートコード：QY2207E01894
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、88ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のパクスロビドAPIの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパクスロビドAPIの世界市場のxxx％を占める「純度≥99％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「新型コロナウイルス感染症経口薬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のパクスロビドAPIの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのパクスロビドAPI市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのパクスロビドAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

パクスロビドAPIのグローバル主要メーカーには、Pfizer、Nanjing Hicin Pharmaceutical、Lepu Medical、HAS Biotech、Novasepなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

パクスロビドAPI市場は、種類と用途によって区分されます。世界のパクスロビドAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度≥99％、純度≥99.5％

【用途別セグメント】
新型コロナウイルス感染症経口薬、研究試薬、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- パクスロビドAPI製品概要
- 種類別市場（純度≥99％、純度≥99.5％）
- 用途別市場（新型コロナウイルス感染症経口薬、研究試薬、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のパクスロビドAPI販売量予測2017-2028
- 世界のパクスロビドAPI売上予測2017-2028
- パクスロビドAPIの地域別販売量
- パクスロビドAPIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別パクスロビドAPI販売量
- 主要メーカー別パクスロビドAPI売上
- 主要メーカー別パクスロビドAPI価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度≥99％、純度≥99.5％）
- パクスロビドAPIの種類別販売量
- パクスロビドAPIの種類別売上
- パクスロビドAPIの種類別価格
・用途別市場規模（新型コロナウイルス感染症経口薬、研究試薬、その他）
- パクスロビドAPIの用途別販売量
- パクスロビドAPIの用途別売上
- パクスロビドAPIの用途別価格
・北米市場
- 北米のパクスロビドAPI市場規模（種類別、用途別）
- 主要国別のパクスロビドAPI市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのパクスロビドAPI市場規模（種類別、用途別）
- 主要国別のパクスロビドAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のパクスロビドAPI市場規模（種類別、用途別）
- 主要国別のパクスロビドAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のパクスロビドAPI市場規模（種類別、用途別）
- 主要国別のパクスロビドAPI市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのパクスロビドAPI市場規模（種類別、用途別）
- 主要国別のパクスロビドAPI市場規模（トルコ、サウジアラビア）
・企業情報
Pfizer、Nanjing Hicin Pharmaceutical、Lepu Medical、HAS Biotech、Novasep
・産業チェーン及び販売チャネル分析
- パクスロビドAPIの産業チェーン分析
- パクスロビドAPIの原材料
- パクスロビドAPIの生産プロセス
- パクスロビドAPIの販売及びマーケティング
- パクスロビドAPIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- パクスロビドAPIの産業動向
- パクスロビドAPIのマーケットドライバー
- パクスロビドAPIの課題
- パクスロビドAPIの阻害要因
・主な調査結果

Market Analysis and Insights: Global Paxlovid API Market
Due to the COVID-19 pandemic, the global Paxlovid API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for % of the Paxlovid API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While COVID-19 Oral Drugs segment is altered to an % CAGR throughout this forecast period.
China Paxlovid API market size is valued at US$ million in 2021, while the US and Europe Paxlovid API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Paxlovid API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Paxlovid API include Pfizer, Nanjing Hicin Pharmaceutical, Lepu Medical, HAS Biotech and Novasep, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Paxlovid API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Paxlovid API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Paxlovid API Scope and Segment
Paxlovid API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Paxlovid API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99%
Purity ≥99.5%
Segment by Application
COVID-19 Oral Drugs
Research Reagents
Other
By Company
Pfizer
Nanjing Hicin Pharmaceutical
Lepu Medical
HAS Biotech
Novasep
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Paxlovid API Product Introduction
1.2 Market by Type
1.2.1 Global Paxlovid API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Market by Application
1.3.1 Global Paxlovid API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 COVID-19 Oral Drugs
1.3.3 Research Reagents
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Paxlovid API Production
2.1 Global Paxlovid API Production Capacity (2017-2028)
2.2 Global Paxlovid API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Paxlovid API Production by Region
2.3.1 Global Paxlovid API Historic Production by Region (2017-2022)
2.3.2 Global Paxlovid API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 India
3 Global Paxlovid API Sales in Volume & Value Estimates and Forecasts
3.1 Global Paxlovid API Sales Estimates and Forecasts 2017-2028
3.2 Global Paxlovid API Revenue Estimates and Forecasts 2017-2028
3.3 Global Paxlovid API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Paxlovid API Sales by Region
3.4.1 Global Paxlovid API Sales by Region (2017-2022)
3.4.2 Global Sales Paxlovid API by Region (2023-2028)
3.5 Global Paxlovid API Revenue by Region
3.5.1 Global Paxlovid API Revenue by Region (2017-2022)
3.5.2 Global Paxlovid API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Paxlovid API Production Capacity by Manufacturers
4.2 Global Paxlovid API Sales by Manufacturers
4.2.1 Global Paxlovid API Sales by Manufacturers (2017-2022)
4.2.2 Global Paxlovid API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Paxlovid API in 2021
4.3 Global Paxlovid API Revenue by Manufacturers
4.3.1 Global Paxlovid API Revenue by Manufacturers (2017-2022)
4.3.2 Global Paxlovid API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Paxlovid API Revenue in 2021
4.4 Global Paxlovid API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Paxlovid API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Paxlovid API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Paxlovid API Sales by Type
5.1.1 Global Paxlovid API Historical Sales by Type (2017-2022)
5.1.2 Global Paxlovid API Forecasted Sales by Type (2023-2028)
5.1.3 Global Paxlovid API Sales Market Share by Type (2017-2028)
5.2 Global Paxlovid API Revenue by Type
5.2.1 Global Paxlovid API Historical Revenue by Type (2017-2022)
5.2.2 Global Paxlovid API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Paxlovid API Revenue Market Share by Type (2017-2028)
5.3 Global Paxlovid API Price by Type
5.3.1 Global Paxlovid API Price by Type (2017-2022)
5.3.2 Global Paxlovid API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Paxlovid API Sales by Application
6.1.1 Global Paxlovid API Historical Sales by Application (2017-2022)
6.1.2 Global Paxlovid API Forecasted Sales by Application (2023-2028)
6.1.3 Global Paxlovid API Sales Market Share by Application (2017-2028)
6.2 Global Paxlovid API Revenue by Application
6.2.1 Global Paxlovid API Historical Revenue by Application (2017-2022)
6.2.2 Global Paxlovid API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Paxlovid API Revenue Market Share by Application (2017-2028)
6.3 Global Paxlovid API Price by Application
6.3.1 Global Paxlovid API Price by Application (2017-2022)
6.3.2 Global Paxlovid API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Paxlovid API Market Size by Type
7.1.1 North America Paxlovid API Sales by Type (2017-2028)
7.1.2 North America Paxlovid API Revenue by Type (2017-2028)
7.2 North America Paxlovid API Market Size by Application
7.2.1 North America Paxlovid API Sales by Application (2017-2028)
7.2.2 North America Paxlovid API Revenue by Application (2017-2028)
7.3 North America Paxlovid API Sales by Country
7.3.1 North America Paxlovid API Sales by Country (2017-2028)
7.3.2 North America Paxlovid API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Paxlovid API Market Size by Type
8.1.1 Europe Paxlovid API Sales by Type (2017-2028)
8.1.2 Europe Paxlovid API Revenue by Type (2017-2028)
8.2 Europe Paxlovid API Market Size by Application
8.2.1 Europe Paxlovid API Sales by Application (2017-2028)
8.2.2 Europe Paxlovid API Revenue by Application (2017-2028)
8.3 Europe Paxlovid API Sales by Country
8.3.1 Europe Paxlovid API Sales by Country (2017-2028)
8.3.2 Europe Paxlovid API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Paxlovid API Market Size by Type
9.1.1 Asia Pacific Paxlovid API Sales by Type (2017-2028)
9.1.2 Asia Pacific Paxlovid API Revenue by Type (2017-2028)
9.2 Asia Pacific Paxlovid API Market Size by Application
9.2.1 Asia Pacific Paxlovid API Sales by Application (2017-2028)
9.2.2 Asia Pacific Paxlovid API Revenue by Application (2017-2028)
9.3 Asia Pacific Paxlovid API Sales by Region
9.3.1 Asia Pacific Paxlovid API Sales by Region (2017-2028)
9.3.2 Asia Pacific Paxlovid API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Paxlovid API Market Size by Type
10.1.1 Latin America Paxlovid API Sales by Type (2017-2028)
10.1.2 Latin America Paxlovid API Revenue by Type (2017-2028)
10.2 Latin America Paxlovid API Market Size by Application
10.2.1 Latin America Paxlovid API Sales by Application (2017-2028)
10.2.2 Latin America Paxlovid API Revenue by Application (2017-2028)
10.3 Latin America Paxlovid API Sales by Country
10.3.1 Latin America Paxlovid API Sales by Country (2017-2028)
10.3.2 Latin America Paxlovid API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Paxlovid API Market Size by Type
11.1.1 Middle East and Africa Paxlovid API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Paxlovid API Revenue by Type (2017-2028)
11.2 Middle East and Africa Paxlovid API Market Size by Application
11.2.1 Middle East and Africa Paxlovid API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Paxlovid API Revenue by Application (2017-2028)
11.3 Middle East and Africa Paxlovid API Sales by Country
11.3.1 Middle East and Africa Paxlovid API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Paxlovid API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Overview
12.1.3 Pfizer Paxlovid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Pfizer Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Pfizer Recent Developments
12.2 Nanjing Hicin Pharmaceutical
12.2.1 Nanjing Hicin Pharmaceutical Corporation Information
12.2.2 Nanjing Hicin Pharmaceutical Overview
12.2.3 Nanjing Hicin Pharmaceutical Paxlovid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Nanjing Hicin Pharmaceutical Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Nanjing Hicin Pharmaceutical Recent Developments
12.3 Lepu Medical
12.3.1 Lepu Medical Corporation Information
12.3.2 Lepu Medical Overview
12.3.3 Lepu Medical Paxlovid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Lepu Medical Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Lepu Medical Recent Developments
12.4 HAS Biotech
12.4.1 HAS Biotech Corporation Information
12.4.2 HAS Biotech Overview
12.4.3 HAS Biotech Paxlovid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 HAS Biotech Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 HAS Biotech Recent Developments
12.5 Novasep
12.5.1 Novasep Corporation Information
12.5.2 Novasep Overview
12.5.3 Novasep Paxlovid API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Novasep Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Novasep Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Paxlovid API Industry Chain Analysis
13.2 Paxlovid API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Paxlovid API Production Mode & Process
13.4 Paxlovid API Sales and Marketing
13.4.1 Paxlovid API Sales Channels
13.4.2 Paxlovid API Distributors
13.5 Paxlovid API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Paxlovid API Industry Trends
14.2 Paxlovid API Market Drivers
14.3 Paxlovid API Market Challenges
14.4 Paxlovid API Market Restraints
15 Key Finding in The Global Paxlovid API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Paxlovid API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity ≥99%
Table 3. Major Manufacturers of Purity ≥99.5%
Table 4. Global Paxlovid API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Paxlovid API Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Paxlovid API Production by Region (2017-2022) & (Tons)
Table 7. Global Paxlovid API Production Market Share by Region (2017-2022)
Table 8. Global Paxlovid API Production by Region (2023-2028) & (Tons)
Table 9. Global Paxlovid API Production Market Share by Region (2023-2028)
Table 10. Global Paxlovid API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Paxlovid API Sales by Region (2017-2022) & (Tons)
Table 12. Global Paxlovid API Sales Market Share by Region (2017-2022)
Table 13. Global Paxlovid API Sales by Region (2023-2028) & (Tons)
Table 14. Global Paxlovid API Sales Market Share by Region (2023-2028)
Table 15. Global Paxlovid API Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Paxlovid API Revenue Market Share by Region (2017-2022)
Table 17. Global Paxlovid API Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Paxlovid API Revenue Market Share by Region (2023-2028)
Table 19. Global Paxlovid API Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Paxlovid API Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Paxlovid API Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Paxlovid API Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Paxlovid API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Paxlovid API Revenue Share by Manufacturers (2017-2022)
Table 25. Paxlovid API Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Paxlovid API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Paxlovid API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paxlovid API as of 2021)
Table 28. Paxlovid API Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Paxlovid API Product Offered
Table 30. Date of Manufacturers Enter into Paxlovid API Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Paxlovid API Sales by Type (2017-2022) & (Tons)
Table 33. Global Paxlovid API Sales by Type (2023-2028) & (Tons)
Table 34. Global Paxlovid API Sales Share by Type (2017-2022)
Table 35. Global Paxlovid API Sales Share by Type (2023-2028)
Table 36. Global Paxlovid API Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Paxlovid API Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Paxlovid API Revenue Share by Type (2017-2022)
Table 39. Global Paxlovid API Revenue Share by Type (2023-2028)
Table 40. Paxlovid API Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Paxlovid API Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Paxlovid API Sales by Application (2017-2022) & (Tons)
Table 43. Global Paxlovid API Sales by Application (2023-2028) & (Tons)
Table 44. Global Paxlovid API Sales Share by Application (2017-2022)
Table 45. Global Paxlovid API Sales Share by Application (2023-2028)
Table 46. Global Paxlovid API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Paxlovid API Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Paxlovid API Revenue Share by Application (2017-2022)
Table 49. Global Paxlovid API Revenue Share by Application (2023-2028)
Table 50. Paxlovid API Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Paxlovid API Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Paxlovid API Sales by Type (2017-2022) & (Tons)
Table 53. North America Paxlovid API Sales by Type (2023-2028) & (Tons)
Table 54. North America Paxlovid API Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Paxlovid API Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Paxlovid API Sales by Application (2017-2022) & (Tons)
Table 57. North America Paxlovid API Sales by Application (2023-2028) & (Tons)
Table 58. North America Paxlovid API Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Paxlovid API Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Paxlovid API Sales by Country (2017-2022) & (Tons)
Table 61. North America Paxlovid API Sales by Country (2023-2028) & (Tons)
Table 62. North America Paxlovid API Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Paxlovid API Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Paxlovid API Sales by Type (2017-2022) & (Tons)
Table 65. Europe Paxlovid API Sales by Type (2023-2028) & (Tons)
Table 66. Europe Paxlovid API Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Paxlovid API Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Paxlovid API Sales by Application (2017-2022) & (Tons)
Table 69. Europe Paxlovid API Sales by Application (2023-2028) & (Tons)
Table 70. Europe Paxlovid API Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Paxlovid API Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Paxlovid API Sales by Country (2017-2022) & (Tons)
Table 73. Europe Paxlovid API Sales by Country (2023-2028) & (Tons)
Table 74. Europe Paxlovid API Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Paxlovid API Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Paxlovid API Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Paxlovid API Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Paxlovid API Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Paxlovid API Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Paxlovid API Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Paxlovid API Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Paxlovid API Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Paxlovid API Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Paxlovid API Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Paxlovid API Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Paxlovid API Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Paxlovid API Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Paxlovid API Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Paxlovid API Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Paxlovid API Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Paxlovid API Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Paxlovid API Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Paxlovid API Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Paxlovid API Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Paxlovid API Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Paxlovid API Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Paxlovid API Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Paxlovid API Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Paxlovid API Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Paxlovid API Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Paxlovid API Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Paxlovid API Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Paxlovid API Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Paxlovid API Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Paxlovid API Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Paxlovid API Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Paxlovid API Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Paxlovid API Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Paxlovid API Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Paxlovid API Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Paxlovid API Revenue by Country (2023-2028) & (US$ Million)
Table 112. Pfizer Corporation Information
Table 113. Pfizer Description and Major Businesses
Table 114. Pfizer Paxlovid API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Pfizer Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Pfizer Recent Development
Table 117. Nanjing Hicin Pharmaceutical Corporation Information
Table 118. Nanjing Hicin Pharmaceutical Description and Major Businesses
Table 119. Nanjing Hicin Pharmaceutical Paxlovid API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Nanjing Hicin Pharmaceutical Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Nanjing Hicin Pharmaceutical Recent Development
Table 122. Lepu Medical Corporation Information
Table 123. Lepu Medical Description and Major Businesses
Table 124. Lepu Medical Paxlovid API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Lepu Medical Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Lepu Medical Recent Development
Table 127. HAS Biotech Corporation Information
Table 128. HAS Biotech Description and Major Businesses
Table 129. HAS Biotech Paxlovid API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. HAS Biotech Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. HAS Biotech Recent Development
Table 132. Novasep Corporation Information
Table 133. Novasep Description and Major Businesses
Table 134. Novasep Paxlovid API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Novasep Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Novasep Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Paxlovid API Distributors List
Table 140. Paxlovid API Customers List
Table 141. Paxlovid API Market Trends
Table 142. Paxlovid API Market Drivers
Table 143. Paxlovid API Market Challenges
Table 144. Paxlovid API Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Paxlovid API Product Picture
Figure 2. Global Paxlovid API Market Share by Type in 2021 & 2028
Figure 3. Purity ≥99% Product Picture
Figure 4. Purity ≥99.5% Product Picture
Figure 5. Global Paxlovid API Market Share by Application in 2021 & 2028
Figure 6. COVID-19 Oral Drugs
Figure 7. Research Reagents
Figure 8. Other
Figure 9. Paxlovid API Report Years Considered
Figure 10. Global Paxlovid API Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 11. Global Paxlovid API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Paxlovid API Production Market Share by Region (2017-2022)
Figure 13. Global Paxlovid API Production Market Share by Region (2023-2028)
Figure 14. Paxlovid API Production Growth Rate in North America (2017-2028) & (Tons)
Figure 15. Paxlovid API Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 16. Paxlovid API Production Growth Rate in China (2017-2028) & (Tons)
Figure 17. Paxlovid API Production Growth Rate in India (2017-2028) & (Tons)
Figure 18. Global Paxlovid API Sales 2017-2028 (Tons)
Figure 19. Global Paxlovid API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Paxlovid API Revenue 2017-2028 (US$ Million)
Figure 21. Global Paxlovid API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global Paxlovid API Sales Market Share by Region (2017-2022)
Figure 23. Global Paxlovid API Sales Market Share by Region (2023-2028)
Figure 24. North America Paxlovid API Sales YoY (2017-2028) & (Tons)
Figure 25. North America Paxlovid API Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe Paxlovid API Sales YoY (2017-2028) & (Tons)
Figure 27. Europe Paxlovid API Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Paxlovid API Sales YoY (2017-2028) & (Tons)
Figure 29. Asia-Pacific Paxlovid API Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America Paxlovid API Sales YoY (2017-2028) & (Tons)
Figure 31. Latin America Paxlovid API Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa Paxlovid API Sales YoY (2017-2028) & (Tons)
Figure 33. Middle East & Africa Paxlovid API Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The Paxlovid API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of Paxlovid API in the World: Market Share by Paxlovid API Revenue in 2021
Figure 36. Paxlovid API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global Paxlovid API Sales Market Share by Type (2017-2028)
Figure 38. Global Paxlovid API Revenue Market Share by Type (2017-2028)
Figure 39. Global Paxlovid API Sales Market Share by Application (2017-2028)
Figure 40. Global Paxlovid API Revenue Market Share by Application (2017-2028)
Figure 41. North America Paxlovid API Sales Market Share by Type (2017-2028)
Figure 42. North America Paxlovid API Revenue Market Share by Type (2017-2028)
Figure 43. North America Paxlovid API Sales Market Share by Application (2017-2028)
Figure 44. North America Paxlovid API Revenue Market Share by Application (2017-2028)
Figure 45. North America Paxlovid API Sales Share by Country (2017-2028)
Figure 46. North America Paxlovid API Revenue Share by Country (2017-2028)
Figure 47. United States Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 48. Canada Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 49. Europe Paxlovid API Sales Market Share by Type (2017-2028)
Figure 50. Europe Paxlovid API Revenue Market Share by Type (2017-2028)
Figure 51. Europe Paxlovid API Sales Market Share by Application (2017-2028)
Figure 52. Europe Paxlovid API Revenue Market Share by Application (2017-2028)
Figure 53. Europe Paxlovid API Sales Share by Country (2017-2028)
Figure 54. Europe Paxlovid API Revenue Share by Country (2017-2028)
Figure 55. Germany Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 56. France Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 58. Italy Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 59. Russia Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific Paxlovid API Sales Market Share by Type (2017-2028)
Figure 61. Asia Pacific Paxlovid API Revenue Market Share by Type (2017-2028)
Figure 62. Asia Pacific Paxlovid API Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific Paxlovid API Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific Paxlovid API Sales Share by Region (2017-2028)
Figure 65. Asia Pacific Paxlovid API Revenue Share by Region (2017-2028)
Figure 66. China Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 67. Japan Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 69. India Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 70. Australia Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 71. China Taiwan Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America Paxlovid API Sales Market Share by Type (2017-2028)
Figure 76. Latin America Paxlovid API Revenue Market Share by Type (2017-2028)
Figure 77. Latin America Paxlovid API Sales Market Share by Application (2017-2028)
Figure 78. Latin America Paxlovid API Revenue Market Share by Application (2017-2028)
Figure 79. Latin America Paxlovid API Sales Share by Country (2017-2028)
Figure 80. Latin America Paxlovid API Revenue Share by Country (2017-2028)
Figure 81. Mexico Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa Paxlovid API Sales Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Paxlovid API Revenue Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Paxlovid API Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Paxlovid API Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Paxlovid API Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa Paxlovid API Revenue Share by Country (2017-2028)
Figure 90. Turkey Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 92. UAE Paxlovid API Revenue (2017-2028) & (US$ Million)
Figure 93. Paxlovid API Value Chain
Figure 94. Paxlovid API Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed

Global Paxlovid API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E2024 2022年5月 91Pages
パクスロビドAPI市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。...

自動車駆動系・電気自動車用接着剤のグローバル市場インサイト・予測（～2028年）

Global Adhesives for Automotive Drive Trains and Electric Mobility Market Insights, Forecast to 2028
QY2207E00725 2022年7月 105Pages
新型コロナウイルス感染症のパンデミックにより、世界の自動車駆動系・電気自動車用接着剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に自動...

高安定性熱伝達流体のグローバル市場インサイト・予測（～2028年）

Global Highly Stable Heat Transfer Fluids Market Insights, Forecast to 2028
QY2207E01129 2022年7月 111Pages
新型コロナウイルス感染症のパンデミックにより、世界の高安定性熱伝達流体の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に高安定性熱伝達流体...

アラミドナノファイバー(ANF)のグローバル市場インサイト・予測（～2028年）

Global Aramid Nanofibers (ANFs) Market Insights, Forecast to 2028
QY2207E00907 2022年7月 70Pages
新型コロナウイルス感染症のパンデミックにより、世界のアラミドナノファイバー(ANF)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にアラ...

コポリエステルエーテルエラストマーのグローバル市場インサイト・予測（～2028年）

Global Co-polyester Ether Elastomer Market Insights, Forecast to 2028
QY2207C0944 2022年7月8日 92Pages
新型コロナウイルス感染症のパンデミックにより、世界のコポリエステルエーテルエラストマーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にコ...

世界のパクスロビドAPI市場予測（～2028年）：純度≥99％、純度≥99.5％ The Paxlovid API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…
世界の乱用試験試薬市場予測（～2028年）：尿検査、唾液検査、血液検査、髪＆汗検査、その他 The Drugs of Abuse Testing Reagents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
世界の経口血糖降下薬市場予測（～2028年）：スルホニル尿素剤（SU）、ダブルグアニジン、グルコシダーゼ阻害剤、インスリン相乗剤 The Oral Hypoglycemic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
がん治療用口腔粘膜炎薬のグローバル市場インサイト・予測（～2028年） Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemoth…
経口用新型コロナウイルス感染症治療剤のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Oral COVID-19 Drug Market Due to the COVID-19 pandemic, the global Oral COVID-19 Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully…